NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call
Rhea-AI Summary
NeuroMetrix (Nasdaq: NURO) has announced its upcoming second quarter 2024 business and financial highlights release, scheduled for August 6, 2024, before the market opens. The company will host a conference call at 8:00 a.m. Eastern Time on the same day to discuss the results.
Participants wishing to join the call and ask questions should register in advance to receive dial-in information and a unique PIN. An audio-only webcast of the call, along with the earnings press release and financial statements, will be available on the company's website. A replay of the call will be accessible for one year in the Investors section of NeuroMetrix's website.
Positive
- None.
Negative
- None.
WOBURN, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2024 second quarter business and financial highlights before the opening of the market on August 6, 2024. The Company will host a conference call at 8:00 a.m., Eastern Time on August 6, 2024.
For participants who wish to access the Q2 2024 Conference Call live via telephone and be able to ask questions, please register in advance here. Upon registering, a dial-in and unique PIN will be provided on screen and via email to join the call. An audio-only webcast of the call, along with the earnings press release and accompanying condensed financial statements, may be accessed in the Investors section of the Company’s website at www.NeuroMetrix.com. Following the conference call, a replay of the call will be available for one year on the Company's Investors section of the website.
About NeuroMetrix
NeuroMetrix is a commercial stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell® is a wearable neuromodulation platform. DPNCheck® is a point-of-care screening test for peripheral neuropathy. For more information, visit www.NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
FAQ
When will NeuroMetrix (NURO) release its Q2 2024 financial results?
What time is NeuroMetrix's (NURO) Q2 2024 earnings conference call?
How can I participate in NeuroMetrix's (NURO) Q2 2024 earnings call?
Where can I access NeuroMetrix's (NURO) Q2 2024 earnings webcast?
